Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.

Carrat F, Fontaine H, Dorival C, Simony M, Diallo A, Hezode C, De Ledinghen V, Larrey D, Haour G, Bronowicki JP, Zoulim F, Asselah T, Marcellin P, Thabut D, Leroy V, Tran A, Habersetzer F, Samuel D, Guyader D, Chazouilleres O, Mathurin P, Metivier S, Alric L, Riachi G, Gournay J, Abergel A, Cales P, Ganne N, Loustaud-Ratti V, D'Alteroche L, Causse X, Geist C, Minello A, Rosa I, Gelu-Simeon M, Portal I, Raffi F, Bourliere M, Pol S, French ANRS CO22 Hepather cohort

Open source

DOI
10.1016/s0140-6736(18)32111-1
Published
2019 Apr 6
Container
Lancet (London, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-18-32111-1,
  title = {Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.},
  author = {Carrat F and Fontaine H and Dorival C and Simony M and Diallo A and Hezode C and De Ledinghen V and Larrey D and Haour G and Bronowicki JP and Zoulim F and Asselah T and Marcellin P and Thabut D and Leroy V and Tran A and Habersetzer F and Samuel D and Guyader D and Chazouilleres O and Mathurin P and Metivier S and Alric L and Riachi G and Gournay J and Abergel A and Cales P and Ganne N and Loustaud-Ratti V and D'Alteroche L and Causse X and Geist C and Minello A and Rosa I and Gelu-Simeon M and Portal I and Raffi F and Bourliere M and Pol S and French ANRS CO22 Hepather cohort},
  year = {2019},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(18)32111-1},
  url = {https://doi.org/10.1016/s0140-6736(18)32111-1}
}

RIS

TY  - JOUR
TI  - Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
AU  - Carrat F
AU  - Fontaine H
AU  - Dorival C
AU  - Simony M
AU  - Diallo A
AU  - Hezode C
AU  - De Ledinghen V
AU  - Larrey D
AU  - Haour G
AU  - Bronowicki JP
AU  - Zoulim F
AU  - Asselah T
AU  - Marcellin P
AU  - Thabut D
AU  - Leroy V
AU  - Tran A
AU  - Habersetzer F
AU  - Samuel D
AU  - Guyader D
AU  - Chazouilleres O
AU  - Mathurin P
AU  - Metivier S
AU  - Alric L
AU  - Riachi G
AU  - Gournay J
AU  - Abergel A
AU  - Cales P
AU  - Ganne N
AU  - Loustaud-Ratti V
AU  - D'Alteroche L
AU  - Causse X
AU  - Geist C
AU  - Minello A
AU  - Rosa I
AU  - Gelu-Simeon M
AU  - Portal I
AU  - Raffi F
AU  - Bourliere M
AU  - Pol S
AU  - French ANRS CO22 Hepather cohort
PY  - 2019
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(18)32111-1
UR  - https://doi.org/10.1016/s0140-6736(18)32111-1
ER  - 

APA

F, C., H, F., C, D., M, S., A, D., C, H., V, D. L., D, L., G, H., JP, B., F, Z., T, A., P, M., D, T., V, L., A, T., F, H., D, S., D, G., O, C., P, M., S, M., L, A., G, R., J, G., A, A., P, C., N, G., V, L., L, D., X, C., C, G., A, M., I, R., M, G., I, P., F, R., M, B., S, P., & cohort, F. A. C. H. (2019). Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(18)32111-1

Source records